Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 5881: PERIO-01: Initial safety experience and immunologic effects of a Class C TLR9 agonist using pressure- enabled drug delivery in a phase 1 trial of hepatic arterial infusion of SD-101 +/- checkpoint inhibition in metastatic uveal melanoma

Cancer Res (2023) 83 (7_Supplement): 5881.

https://doi.org/10.1158/1538-7445.AM2023-5881

Published: 04 April 2023

View articletitled, Abstract 5881: PERIO-01: Initial safety experience and immunologic effects of a Class C TLR9 agonist using pressure- enabled drug delivery in a phase 1 trial of hepatic arterial infusion of SD-101 +/- checkpoint inhibition in metastatic uveal melanoma

Journal Articles

Abstract A11: Prognostic model for disease-specific survival in anorectal melanoma

Cancer Res (2020) 80 (19_Supplement): A11.

https://doi.org/10.1158/1538-7445.MEL2019-A11

Published: 02 October 2020

View articletitled, Abstract A11: Prognostic model for disease-specific survival in anorectal melanoma

Journal Articles

Abstract P3-08-38: Primary cutaneous melanoma of the breast in women. A retrospective study of 82 patients

Madhuchhanda Roy, Junsheng Ma, Aysegul A Sahin, Senthilkumar Damodaran, Michael T Tetzlaff, Jonathan L Curry, Ana M Ciurea, Jing Ning, Carlos A Torres-Cabala, Doina Ivan, Phyu P Aung, Merrick I Ross, Jeffrey E Gershenwald, Michael A Davies, Victor G Prieto, Priyadharsini Nagarajan

Cancer Res (2020) 80 (4_Supplement): P3-08-38.

https://doi.org/10.1158/1538-7445.SABCS19-P3-08-38

Published: 15 February 2020

View articletitled, Abstract P3-08-38: Primary cutaneous melanoma of the breast in women. A retrospective study of 82 patients

Journal Articles

Abstract 4342: Inverted sinonasal papilloma and associated carcinoma-transcriptome analysis and out-hoxing developmental genes

Achim H. Bell, Ehab Y. Hanna, Randal S. Weber, Victor G. Prieto, Diana Bell

Cancer Res (2018) 78 (13_Supplement): 4342.

https://doi.org/10.1158/1538-7445.AM2018-4342

Published: 01 July 2018

View articletitled, Abstract 4342: Inverted sinonasal papilloma and associated carcinoma-transcriptome analysis and out-hoxing developmental genes

Journal Articles

Abstract 599: MS17-38 mAb targeting of PODXL-v2 inhibits gastric cancer growth and metastasis

Runhua Feng, Ming Li, Yuling Wang, Dongqing Zhang, Xiaolian Gao, Xuehua Chen, Joe X. Zhou, Victor G. Prieto, Jian H. Song, Shenying Fang, Binya Liu, Zhenggang Zhu, Xiangcang Ye, Lee M. Ellis, Mason Lu, Jeffery E. Lee

Cancer Res (2016) 76 (14_Supplement): 599.

https://doi.org/10.1158/1538-7445.AM2016-599

Published: 15 July 2016

View articletitled, Abstract 599: MS17-38 mAb targeting of PODXL-v2 inhibits gastric cancer growth and metastasis

Journal Articles

Abstract 3570: Differential expression of the melanoma inhibitor of apoptosis protein (ML-IAP)/Livin in patients with ulcerated and non-ulcerated melanomas

Nitin Chakravarti, Dawen Sui, Denái R. Milton, Wen-Jen Hwu, Elizabeth A. Grimm, Victor G. Prieto

Cancer Res (2016) 76 (14_Supplement): 3570.

https://doi.org/10.1158/1538-7445.AM2016-3570

Published: 15 July 2016

View articletitled, Abstract 3570: Differential expression of the melanoma inhibitor of apoptosis protein (ML-IAP)/Livin in patients with ulcerated and non-ulcerated melanomas

Journal Articles

Abstract 596: Differential cellular localization of Ephrin receptor tyrosine kinase B4 (EphB4) in melanoma progression

Nitin Chakravarti, Jonathan L. Curry, Roland L. Bassett, Victor G. Prieto

Cancer Res (2015) 75 (15_Supplement): 596.

https://doi.org/10.1158/1538-7445.AM2015-596

Published: 01 August 2015

View articletitled, Abstract 596: Differential cellular localization of Ephrin receptor tyrosine kinase B4 (EphB4) in melanoma progression

Journal Articles

Abstract CT332: Biomarker analysis predicts antitumor activity of Ipilimumab therapy in patients with refractory metastatic melanoma

Nitin Chakravarti, Isabella C. Glitza, Van A. Trinh, Roland L. Bassett, Wen-Jen Hwu, Victor G. Prieto

Cancer Res (2014) 74 (19_Supplement): CT332.

https://doi.org/10.1158/1538-7445.AM2014-CT332

Published: 01 October 2014

View articletitled, Abstract CT332: Biomarker analysis predicts antitumor activity of Ipilimumab therapy in patients with refractory metastatic melanoma

Journal Articles

Abstract 463: Differential cellular localization of programmed death ligand 1 (PD-L1) and enhanced expression of programmed death-1 (PD-1) in melanoma progression.

Nitin Chakravarti, Roland Bassett, Wen-Jen Hwu, Doina Ivan, Jonathan L. Curry, Victor G. Prieto

Cancer Res (2013) 73 (8_Supplement): 463.

https://doi.org/10.1158/1538-7445.AM2013-463

Published: 15 April 2013

View articletitled, Abstract 463: Differential cellular localization of programmed death ligand 1 (PD-L1) and enhanced expression of programmed death-1 (PD-1) in melanoma progression.

Journal Articles

In Vivo Diagnosis of Melanoma and Nonmelanoma Skin Cancer Using Oblique Incidence Diffuse Reflectance Spectrometry

Alejandro Garcia-Uribe, Jun Zou, Madeleine Duvic, Jeong Hee Cho-Vega, Victor G. Prieto, Lihong V. Wang

Cancer Res (2012) 72 (11): 2738–2745.

https://doi.org/10.1158/0008-5472.CAN-11-4027

Published: 31 May 2012

View articletitled, In Vivo Diagnosis of Melanoma and Nonmelanoma Skin Cancer Using Oblique Incidence Diffuse Reflectance Spectrometry

Journal Articles

Abstract 5220: Increased expression of formyl peptide receptor (FPR) and formyl peptide receptor like-1 (FPRL1) correlates with high-risk clinical/histologic features in melanoma

Nitin Chakravarti, Vijay G. R. Peddareddigari, Carla L. Warneke, Marcella M. Johsnon, Patrick Hwu, Victor G. Prieto

Cancer Res (2011) 71 (8_Supplement): 5220.

https://doi.org/10.1158/1538-7445.AM2011-5220

Published: 15 April 2011

View articletitled, Abstract 5220: Increased expression of formyl peptide receptor (FPR) and formyl peptide receptor like-1 (FPRL1) correlates with high-risk clinical/histologic features in melanoma

Journal Articles

Abstract 1486: Increased expression and phosphorylation of eukaryotic initiation factor 4E (eIF4E) and 4E-binding protein (4E-BP1) correlates with disease progression and high risk clinical/pathological features in melanoma

Nitin Chakravarti, Carla L. Warneke, Marcella M. Johnson, Michael A. Davies, Victor G. Prieto

Cancer Res (2010) 70 (8_Supplement): 1486.

https://doi.org/10.1158/1538-7445.AM10-1486

Published: 15 April 2010

View articletitled, Abstract 1486: Increased expression and phosphorylation of eukaryotic initiation factor 4E (eIF4E) and 4E-binding protein (4E-BP1) correlates with disease progression and high risk clinical/pathological features in melanoma

Journal Articles

Polymorphisms of Fas and the Fas ligand increase the risk of cutaneous malignant melanoma

Chunying Li, Dereck Larson, Zhengdong Zhang, Zhensheng Liu, Sara S. Strom, Jeffrey E. Gershenwald, Victor G. Prieto, Jeffrey E. Lee, Merrick I. Ross, Paul F. Mansfield, Janice N Cormier, Madeleine Duvic, Elizabeth A. Grimm, Qingyi Wei

Cancer Res (2006) 66 (8_Supplement): 411–412.

Published: 15 April 2006

View articletitled, Polymorphisms of Fas and the Fas ligand increase the risk of cutaneous malignant melanoma

Journal Articles

Quantitative analysis of melanocytic tissue array reveals inverse correlation between AP-2α and PAR-1 expression during melanoma progression

Carmen S. Tellez, Darren Davis, Victor G. Prieto, Jeffrey E. Gershenwald, Marcella M. Johnson, Marya McCarty, Menashe Bar-Eli

Cancer Res (2006) 66 (8_Supplement): 433.

Published: 15 April 2006

View articletitled, Quantitative analysis of melanocytic tissue array reveals inverse correlation between AP-2α and PAR-1 expression during melanoma progression

Journal Articles

Automated Quantitative Analysis of Activator Protein-2α Subcellular Expression in Melanoma Tissue Microarrays Correlates with Survival Prediction

Aaron J. Berger, Darren W. Davis, Carmen Tellez, Victor G. Prieto, Jeffrey E. Gershenwald, Marcella M. Johnson, David L. Rimm, Menashe Bar-Eli

Cancer Res (2005) 65 (23): 11185–11192.

https://doi.org/10.1158/0008-5472.CAN-05-2300

Published: 01 December 2005

View articletitled, Automated Quantitative Analysis of Activator Protein-2α Subcellular Expression in Melanoma Tissue Microarrays Correlates with Survival Prediction

Journal Articles

Differential expression of retinoid receptors in ocular and extraocular sebaceous cell carcinomas

Nitin Chakravarti, Bita Esmaeli, Hossein G. Saadati, Adel K. El-Naggar, Abdul Diwan, Victor G. Prieto, Reuben Lotan

Cancer Res (2005) 65 (9_Supplement): 1156.

Published: 01 May 2005

View articletitled, Differential expression of retinoid receptors in ocular and extraocular sebaceous cell carcinomas

Journal Articles

Up-regulation of Flotillin-2 Is Associated with Melanoma Progression and Modulates Expression of the Thrombin Receptor Protease Activated Receptor 1

Parul Hazarika, Marya F. McCarty, Victor G. Prieto, Saira George, Daniel Babu, Dimpy Koul, Menashe Bar-Eli, Madeleine Duvic

Cancer Res (2004) 64 (20): 7361–7369.

https://doi.org/10.1158/0008-5472.CAN-04-0823

Published: 15 October 2004

View articletitled, Up-regulation of Flotillin-2 Is Associated with Melanoma Progression and Modulates Expression of the Thrombin Receptor Protease Activated Receptor 1

Journal Articles

A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

Cancer Res (2004) 64 (17): 5913–5919.

https://doi.org/10.1158/0008-5472.CAN-04-0085

Published: 01 September 2004

View articletitled, A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5881: PERIO-01: Initial safety experience and immunologic effects of a Class C TLR9 agonist using pressure- enabled drug delivery in a phase 1 trial of hepatic arterial infusion of SD-101 +/- checkpoint inhibition in metastatic uveal melanoma

Abstract A11: Prognostic model for disease-specific survival in anorectal melanoma

Abstract P3-08-38: Primary cutaneous melanoma of the breast in women. A retrospective study of 82 patients

Abstract 4342: Inverted sinonasal papilloma and associated carcinoma-transcriptome analysis and out-hoxing developmental genes

Abstract 599: MS17-38 mAb targeting of PODXL-v2 inhibits gastric cancer growth and metastasis

Abstract 3570: Differential expression of the melanoma inhibitor of apoptosis protein (ML-IAP)/Livin in patients with ulcerated and non-ulcerated melanomas

Abstract 596: Differential cellular localization of Ephrin receptor tyrosine kinase B4 (EphB4) in melanoma progression

Abstract CT332: Biomarker analysis predicts antitumor activity of Ipilimumab therapy in patients with refractory metastatic melanoma

Abstract 463: Differential cellular localization of programmed death ligand 1 (PD-L1) and enhanced expression of programmed death-1 (PD-1) in melanoma progression.

In Vivo Diagnosis of Melanoma and Nonmelanoma Skin Cancer Using Oblique Incidence Diffuse Reflectance Spectrometry

Abstract 5220: Increased expression of formyl peptide receptor (FPR) and formyl peptide receptor like-1 (FPRL1) correlates with high-risk clinical/histologic features in melanoma

Abstract 1486: Increased expression and phosphorylation of eukaryotic initiation factor 4E (eIF4E) and 4E-binding protein (4E-BP1) correlates with disease progression and high risk clinical/pathological features in melanoma

Polymorphisms of Fas and the Fas ligand increase the risk of cutaneous malignant melanoma

Quantitative analysis of melanocytic tissue array reveals inverse correlation between AP-2α and PAR-1 expression during melanoma progression

Automated Quantitative Analysis of Activator Protein-2α Subcellular Expression in Melanoma Tissue Microarrays Correlates with Survival Prediction

Differential expression of retinoid receptors in ocular and extraocular sebaceous cell carcinomas

Up-regulation of Flotillin-2 Is Associated with Melanoma Progression and Modulates Expression of the Thrombin Receptor Protease Activated Receptor 1

A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only